Abstract:P2X receptors are extracellular ATP-gated ion channels that form homo-or heterotrimers and consist of seven subtypes. They are expressed in various tissues, including neuronal and nonneuronal cells, and play critical roles in physiological processes such as neurotransmission, inflammation, pain, and cancer. As a result, P2X receptors have attracted considerable interest as drug targets, and various competitive inhibitors have been developed. However, although several P2X receptor structures from different subtypes have been reported, the limited structural information of P2X receptors in complex with competitive antagonists hampers the understanding of orthosteric inhibition, hindering the further design and optimization of those antagonists for drug discovery. Here, we determined the cryo-EM structures of the mammalian P2X7 receptor in complex with two classical competitive antagonists of pyridoxal-5’-phosphate derivatives, PPNDS and PPADS, at 3.3 and 3.6 Å resolution, respectively, and performed structure-based mutational analysis by patch-clamp recording as well as MD simulations. Our structures revealed the orthosteric site for PPADS/PPNDS, and structural comparison with the previously reported apo-and ATP-bound structures showed how PPADS/PPNDS binding inhibits the conformational changes associated with channel activation. In addition, structure-based mutational analysis identified key residues involved in the PPNDS sensitivity of P2X1 and P2X3, which are known to have higher affinity for PPADS/PPNDS than other P2X subtypes. Overall, our work provides structural insights into the orthosteric inhibition and subtype specificity of P2X receptors by the classical P2X antagonists, pyridoxal-5’-phosphate derivatives, thereby facilitating the rational design of novel competitive antagonists for P2X receptors.

Human P2X4 receptor gating is modulated by a stable cytoplasmic cap and a unique allosteric pocket

P2X7 receptors exhibit at least three modes of allosteric antagonism

Cryo-EM structures of the human P2X1 receptor reveal subtype-specific architecture and antagonism by supramolecular ligand-binding

Full-Length P2X7 Structures Reveal How Palmitoylation Prevents Channel Desensitization

P2X 7 receptors exhibit at least three modes of allosteric antagonism

Structural insights into the orthosteric inhibition of P2X receptors by non-ATP analog antagonists

Structural Insights into the Allosteric Inhibition of P2X4 Receptors

Structural insights into the orthosteric inhibition of P2X receptors by non-ATP-analog antagonists

Insights into the Channel Gating of P2X Receptors from Structures, Dynamics and Small Molecules

Subtype-Specific Ligand Binding and Activation Gating in Homomeric and Heteromeric P2X Receptors

A conserved residue in the P2X4 receptor has a nonconserved function in ATP recognition

Structural insights into the human P2X1 receptor and ligand interactions

High-affinity agonism at the P2X7 receptor is mediated by three residues outside the orthosteric pocket

Ionotropic purinergic receptor 7 (P2X7) channel structure and pharmacology provides insight regarding non-nucleotide agonism

A Second Drug Binding Site in P2X3

Finely ordered intracellular domain harbors an allosteric site to modulate physiopathological function of P2X3 receptors

Molecular Mechanisms of Human P2X3 Receptor Channel Activation and Modulation by Divalent Cation Bound ATP

A shared mechanism for TNP-ATP recognition by members of the P2X receptor family

Molecular determinants for agonist recognition and discrimination in P2X2 receptors

Conductance of P2x(4) Purinergic Receptor is Determined by Conformational Equilibrium in the Transmembrane Region

Relative motions between left flipper and dorsal fin domains favour P2X4 receptor activation